tert-Butyl 4-benzoylpiperidine-1-carboxylate
CAS: 193217-39-9
Ref. 3D-THA21739
250mg | 244,00 € | ||
2500mg | 986,00 € |
Informação sobre produto
Tert-butyl 4-benzoylpiperidine-1-carboxylate (TBCPC) is a novel amide antagonist that has been shown to inhibit HIV entry into cells. TBCPC has been shown to have an oral bioavailability of 100% and a half-life of 10 hours in rats. This compound also had no effect on the pharmacokinetic profile of other drugs, which could make it a good candidate for replacing other anti-HIV drugs. TBCPC has the potential to be developed as a ccr5 antagonist and may have potential applications in treating diseases such as cancer, inflammatory bowel disease, and AIDS.
Propriedades químicas
Consulta técnica sobre: 3D-THA21739 tert-Butyl 4-benzoylpiperidine-1-carboxylate
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.